Patna (Bihar), Sept 30, 2025: RJD Chief Lalu Prasad offered prayers before Maa Durga at a Durga Puja pandal in Patna. 'Starting to kick in': Trump hints at $1,000–$2,000 'tariff dividend' for ...

Creating simple data classes in Java traditionally required substantial boilerplate code. Consider how we would represent Java’s mascots, Duke and Juggy: public class JavaMascot { private final String ...

Durga Puja 2025 celebrations have taken over Kolkata, and communities have unveiled their unique pandal designs. Some are futuristic, some are eco-friendly, and some are based on social themes. We ...

Durga Puja 2025: Durga Puja is not just a religious festival but a vibrant cultural celebration that brings communities together. Rooted in Hindu mythology, it marks the victory of good over evil and ...

Oracle’s Java team sat down with me last week for a fast-moving briefing on Java 25 and the broader direction of the platform. The headline: JDK 25 is an LTS release, the second on Oracle’s new ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. This article dives into the happens-before ...

Durga Puja in Delhi is not just a festival; it’s a celebration that brings the city together to worship Maa Durga. While Kolkata is known for its grand Durga Pujo, Delhi also celebrates the festival ...

Novartis may have abandoned one Sjögren's syndrome asset this year, but it looks like the drugmaker has a winner on its hands with another candidate. The Swiss pharma had been evaluating ianalumab, a ...

DURGA PRASAD PANIGRAHI bearing DIN number 11081171 is currently the director of ACQUIREX ACQUISITION LLP. DURGA PRASAD PANIGRAHI was first appointed as the director . The information above is compiled ...

After exiting the FDA less than two weeks ago for unclear reasons, Vinay Prasad is once again director of the Center for Biologics Evaluation and Research, HHS confirmed to several outlets Saturday.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...